Due to the challenge of directly targeting the MYC oncoprotein in cancer therapy, we aimed to identify key interactors that could be targeted. We began by conducting a mass spectrometry analysis to identify potential binding proteins of MYC in the HCC cell line MHCC97H, which stably expresses Flag-tagged MYC.